Everwell supports programs and partners to implement digital adherence technologies (DATs) to provide user-centric approaches to improving adherence and overall treatment recovery. Everwell has experience developing, procuring, and deploying DATs at scale in many environments globally. To support DAT rollouts, we have provided 99DOTS envelopes for countries, states, NGOs, and other partners looking to use DATs in their programmatic setting.
Having supported the very first deployments of 99DOTS, Everwell has also made custom designs for new form factors, artwork modifications including local language and custom graphics, and have supported other organizations to be able to sustainably manufacture and procure their own envelopes. We have supported large state-wide deployments in India, including procurement, platform enhancements, capacity building and training support, and implementation design on escalation protocols.
Please do contact us if you are interested in support with your DAT deployment, including 99DOTS, evriMED/MERM devices, or video-observed therapy (VOT).
For partners in India, we can support procurement and supply of 99DOTS Envelopes by Everwell at ₹15 / envelope (excluding GST). For high volume orders, custom requests, or partners in other countries, please do contact us for a quotation at contact@everwell.org. For any other questions about 99DOTS or Everwell, please visit our website at https://everwell.org or reach out to us by email.
Each envelope is designed to fit a specific drug form factor. When requesting envelopes, be sure to request the appropriate envelope that fits the available manufacturer and drug combination that you have available.
Available envelopes for India:
Envelope: Lupin 4FDC
Manufacturer: Lupin
Combination: 4FDC
Phase: Intensive phase for drug-sensitive treatment
Envelope: Lupin 3FDC
Manufacturer: Lupin
Combination: 3FDC
Phase: Continuation phase for drug-sensitive treatment
Envelope: Macleods 4FDC
Manufacturer: Macleods
Combination: 4FDC
Phase: Intensive phase for drug-sensitive treatment
Envelope: Macleods 3FDC
Manufacturer: Macleods
Combination: 3FDC
Phase: Continuation phase for drug-sensitive treatment
Comments